Geode Capital Management
CDTX icon

Geode Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.1M Buy
372,010
+317,027
+577% +$15.4M ﹤0.01% 2007
2025
Q1
$1.18M Buy
54,983
+1,915
+4% +$41.3K ﹤0.01% 3249
2024
Q4
$1.43M Buy
53,068
+170
+0.3% +$4.57K ﹤0.01% 3243
2024
Q3
$569K Buy
52,898
+9,771
+23% +$105K ﹤0.01% 3548
2024
Q2
$515K Sell
43,127
-795,159
-95% -$9.5M ﹤0.01% 3558
2024
Q1
$771K Buy
838,286
+32,415
+4% +$29.8K ﹤0.01% 3458
2023
Q4
$640K Hold
805,871
﹤0.01% 3523
2023
Q3
$759K Buy
805,871
+78,161
+11% +$73.7K ﹤0.01% 3438
2023
Q2
$822K Buy
727,710
+68,043
+10% +$76.9K ﹤0.01% 3433
2023
Q1
$838K Buy
659,667
+66,943
+11% +$85K ﹤0.01% 3424
2022
Q4
$448K Buy
592,724
+7,743
+1% +$5.85K ﹤0.01% 3705
2022
Q3
$367K Buy
584,981
+82,932
+17% +$52K ﹤0.01% 3893
2022
Q2
$245K Buy
502,049
+25,973
+5% +$12.7K ﹤0.01% 4141
2022
Q1
$396K Buy
476,076
+94,458
+25% +$78.6K ﹤0.01% 4060
2021
Q4
$484K Hold
381,618
﹤0.01% 4064
2021
Q3
$854K Buy
381,618
+17,456
+5% +$39.1K ﹤0.01% 3763
2021
Q2
$735K Sell
364,162
-226,206
-38% -$457K ﹤0.01% 3747
2021
Q1
$1.57M Buy
590,368
+134,632
+30% +$358K ﹤0.01% 3371
2020
Q4
$911K Buy
455,736
+7,654
+2% +$15.3K ﹤0.01% 3392
2020
Q3
$1.28M Buy
448,082
+9,328
+2% +$26.6K ﹤0.01% 3113
2020
Q2
$1.62M Buy
438,754
+218,745
+99% +$807K ﹤0.01% 2956
2020
Q1
$545K Buy
220,009
+102,271
+87% +$253K ﹤0.01% 3250
2019
Q4
$452K Buy
117,738
+1,746
+2% +$6.7K ﹤0.01% 3530
2019
Q3
$231K Buy
115,992
+49,017
+73% +$97.6K ﹤0.01% 3716
2019
Q2
$112K Buy
66,975
+4,695
+8% +$7.85K ﹤0.01% 3935
2019
Q1
$165K Hold
62,280
﹤0.01% 3782
2018
Q4
$146K Hold
62,280
﹤0.01% 3765
2018
Q3
$274K Hold
62,280
﹤0.01% 3657
2018
Q2
$323K Buy
62,280
+18,589
+43% +$96.4K ﹤0.01% 3570
2018
Q1
$174K Hold
43,691
﹤0.01% 3730
2017
Q4
$297K Sell
43,691
-4,301
-9% -$29.2K ﹤0.01% 3539
2017
Q3
$388K Hold
47,992
﹤0.01% 3445
2017
Q2
$359K Sell
47,992
-21,555
-31% -$161K ﹤0.01% 3482
2017
Q1
$542K Buy
69,547
+127
+0.2% +$990 ﹤0.01% 3279
2016
Q4
$721K Buy
69,420
+31,310
+82% +$325K ﹤0.01% 3138
2016
Q3
$436K Buy
38,110
+1,870
+5% +$21.4K ﹤0.01% 3304
2016
Q2
$373K Buy
36,240
+9,215
+34% +$94.8K ﹤0.01% 3340
2016
Q1
$343 Buy
27,025
+577
+2% +$7 ﹤0.01% 3412
2015
Q4
$453K Buy
26,448
+4,761
+22% +$81.5K ﹤0.01% 3319
2015
Q3
$275K Buy
+21,687
New +$275K ﹤0.01% 3527